Menopause: The Journal of The North American Menopause Society Vol. 17, No. 1, pp. 23/24 DOI: 10.1097/gme.0b013e3181cdd4a7 * 2010 by The North American Menopause Society 5 Text printed on acid-free paper NAMS continuing medical education activity Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society This position statement, which begins on page 25, has been COMMERCIAL SUPPORT designated a continuing medical education (CME) activity from The CME activity is supported by an unrestricted educa- The North American Menopause Society (NAMS). tional grant from the Alliance for Better Bone Health, a collaboration between Warner Chilcott plc and its affiliates GOAL and sanofi-aventis (US). To demonstrate an increase in, or affirmation of, current knowledge regarding the management of osteoporosis in ACKNOWLEDGMENTS postmenopausal women. NAMS appreciates the contributions of the following members of the Osteoporosis Editorial Board: Sydney L. Bonnick, MD, FACP, LEARNING OBJECTIVES Medical Director, Clinical Research Center of North Texas, Adjunct After reading this position statement, participants should Professor, Departments of Biology and Kinesiology, University of be able to: North Texas, Denton, TX; Steven T. Harris, MD, FACP, Clinical Professor of Medicine, University of California, San Francisco, San & Describe the effect of menopause and aging on bone Francisco, CA; David L. Kendler, MD, FRCPC, Associate Professor health. of Medicine, University of British Columbia, Vancouver, BC, Canada; Michael R. McClung, MD, Director, Oregon Osteoporosis & Identify risk factors that contribute to fracture risk. Center, Portland, OR; and Stuart L. Silverman, MD, FACP, FACR, & Discuss the assessments of risk factors for fracture and Attending Physician, Cedars-Sinai Medical Center, Clinical Professor how to rule out secondary causes of osteoporosis. of Medicine and Rheumatology, David Geffen School of Medicine, & Identify nonpharmacologic and lifestyle approaches to University of California at Los Angeles, Medical Director, Osteo- prevent bone loss and fractures. porosis Medical Center Clinical Research Center, Beverly Hills, CA. The position statement was reviewed and approved by the 2008- & Review the effects of various therapeutic agents on 2009 NAMS Board of Trustees: JoAnn V. Pinkerton, MD, NCMP preventing osteoporotic fracture; understand their effects (President), Professor of Obstetrics and Gynecology, Vice Chair for on bone density and turnover. Academic Affairs, Director, Midlife Health, University of Virginia & Develop individual treatment strategies to reduce mor- Health Sciences Center, Charlottesville, VA; Cynthia A. Stuenkel, bidity and improve quality of life based on results of MD, NCMP (President-Elect), Clinical Professor of Medicine, University of California, San Diego, La Jolla, CA; Steven R. clinical trials. Goldstein, MD, NCMP (Treasurer), Professor of Obstetrics and & Understand the clinical effects of discontinuing different Gynecology, New York University School of Medicine, New York, antiresorptive and anabolic therapies. NY; Thomas B. Clarkson, DVM (Secretary), Professor of Compa- rative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC; Elizabeth Contestabile, RN, BScN, NCMP, TARGET AUDIENCE Nurse Educator, Shirley E. Greenberg Women_s Health Centre, The Ottawa Hospital, Riverside Campus, Ottawa, ON, Canada; Robert R. This educational activity has been developed to meet the Freedman, PhD, Professor, Departments of Psychiatry and Obstetrics educational needs of healthcare professionals who provide and Gynecology, Wayne State University School of Medicine, care to postmenopausal women. Detroit, MI; Victor W. Henderson, MD, MS, NCMP, Professor, Departments of Health Research & Policy and of Neurology & ACCREDITATION Neurological Sciences, Stanford University School of Medicine, Stanford, CA; Risa Kagan, MD, FACOG, CCD, NCMP, Clinical The North American Menopause Society (NAMS) is ac- Professor, Department of Obstetrics, Gynecology, and Reproductive credited by the Accreditation Council for Continuing Medical Sciences, University of California, San Francisco, East Bay Physi- Education (ACCME) to provide continuing medical educa- cians Medical Group, Berkeley, CA; JoAnn E. Manson, MD, DrPH, Professor of Medicine and the Elizabeth Fay Brigham Professor of tion for physicians. NAMS designates this educational acti- _ i Women s Health, Harvard Medical School, Chief of Preventive vity for a maximum of 2 AMA PRA Category 1 Credit(s) . Medicine and Co-Director, Connors Center for Women’s Health and Physicians should only claim credit commensurate with the Gender Biology, Brigham and Women_s Hospital, Boston, MA; extent of their participation in the activity. Diane T. Pace, PhD, FNP-BC, CCD, FAANP, NCMP, Assistant Dean for Faculty Practice, Director, Center for Health Evaluation and INSTRUCTIONS Lifestyle Promotion, University of Tennessee Health Science Center, Memphis, TN; Jan L. Shifren, MD, NCMP, Associate Professor of Program participants should complete the CME self- Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical assessment examination provided on page 55. School, Director, Menopause Program, Vincent Obstetrics and Menopause, Vol. 17, No. 1, 2010 23 CONTINUING MEDICAL EDUCATION Gynecology Service, Massachusetts General Hospital, Boston, Novartis, Procter & Gamble, Wyeth; Speaker_s BureauVEli Lilly, MA; Leon Speroff, MD, Professor of Obstetrics and Gynecology, Merck, Procter & Gamble, Roche. Oregon Health and Science University, Portland, OR; Michelle P. For the NAMS Board of Trustees, Dr. Clarkson reports: Warren, MD, Medical Director, Center for Menopause, Hormonal Consultant/Advisory BoardVWyeth; Grants/Research SupportV Disorders, and Women_s Health, Professor of Medicine, Obstetrics Wyeth. Ms. Contestabile reports: No significant financial relation- and Gynecology, Wyeth Professor of Women_s Health, Columbia ships. Dr. Freedman reports: Consultant/Advisory BoardVAlexza Presbyterian Medical Center, Department of Obstetrics and Gynecol- Pharmaceuticals, Depomed, Duramed, Eli Lilly, GlaxoSmithKline, ogy,NewYork,NY;Isaac Schiff, MD (Ex Officio), Joe Vincent Novartis, Organon, Pfizer, Procter & Gamble, Vela Pharmaceuticals, Meigs Professor of Gynecology, Harvard Medical School, Chief, Wyeth. Dr. Goldstein reports: Board of Directors/TrusteesVNYU Vincent Obstetrics and Gynecology Service, Massachusetts General School of Medicine Alumni Corporation; Director, SonoSite; Hospital, Boston, MA; and Wulf H. Utian, MD, PhD, DSc(Med), Consultant/Advisory BoardVBoehringer Ingelheim, Cook Ob/Gyn, NCMP (Ex Officio), Arthur H. Bill Professor Emeritus of Reproduc- Eli Lilly, GlaxoSmithKline, Merck, Novo Nordisk, Pfizer, Philips tive Biology, Case Western Reserve University School of Medicine, Ultrasound, Procter & Gamble, Upsher-Smith; Speaker_sBureauVEli Chairman, Advisory Board, Rapid Medical Research, Consultant, Lilly, Pfizer, Procter & Gamble, Wyeth. Dr. Henderson reports: Obstetrics, Gynecology and Women_s Health Institute, Cleveland Consultant/Advisory BoardVAlexander Foundation for Women_s Clinic, Executive Director, The North American Menopause Society, Health, Council on Menopause Management, Geriatric Neurology Cleveland, OH. Section of the American Academy of Neurology, John Douglas The Society also acknowledges the editorial contributions of French Alzheimer_s Foundation; National Aphasia Association. Margery L.S. Gass, MD, NCMP, NAMS Executive Director Dr. Kagan reports: Consultant/Advisory BoardVAventis, Depomed, Designate, Angela M. Bilancini, NAMS Associate Medical Editor; Eli Lilly, Medtronic, Procter & Gamble, Wyeth; Grants/Research Pamela P. Boggs, MBA, NAMS Director of Education and Devel- SupportVBoehringer Ingelheim, Depomed, Eli Lilly, Novartis, opment; and Kathryn J. Wisch, NAMS Managing Editor. Procter & Gamble; Speaker_s BureauVEli Lilly, GlaxoSmithKline, Novartis, Novogyne. Dr. Manson reports: No significant financial relationships. Dr. Pace reports: Consultant/Advisory BoardVBayer, DISCLOSURE Novo Nordisk, Wyeth; Speaker_s BureauVBayer, King Pharmaceu- NAMS is committed to ensuring balance, independence, and ticals, Novo Nordisk, Pfizer, Wyeth. Dr. Pinkerton reports: Board objectivity in all its educational activities. All those involved in the of Directors/TrusteesVNational Women_s Health Resource Center; development of a continuing medical education (CME) activity are Consultant/Advisory BoardVBoehringer Ingelheim, Duramed, required to disclose financial relationships they or their spouse/partner Merck, Novo Nordisk, Wyeth; Speaker_s BureauVMerck; Research have had during the last 12 months with a commercial interest whose SupportVSolvay, Wyeth. Dr. Shifren reports: Consultant/Advisory products or services are discussed in the CME activity content, or BoardVBoehringer Ingelheim, Eli Lilly, New England Research with any commercial supporters of the activity, over which they have Institutes; Grants/Research Support: Procter & Gamble. Dr. Schiff control. reports: Chair, Medical Advisory BoardVPause, consumer maga- For the Osteoporosis Editorial Board, Dr. Bonnick reports: zine of American College of Obstetricians & Gynecologists. Dr. Advisory BoardVAmgen, Merck, Wyeth; Research SupportV Speroff reports: Consultant/Advisory Board: Warner Chilcott. Dr. Amgen, Merck, Takeda, Wyeth; Speaker_s BureauVAmgen, Novartis, Stuenkel reports: Stock/ShareholderVAbbott Laboratories, Johnson Wyeth. Dr. Harris reports: